ClinicalTrials.Veeva

Menu
Hong Kong Center for Clinical Research | Hong Kong, China logo

Hong Kong Center for Clinical Research | Hong Kong, China

Research site

Site insights

Top conditions

Top treatments

AMZ001
JTA-004
Rocatinlimab
Baxdrostat
LEVI-04

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Edward Wong

Verified by this site

Active trials

5 of 6 total trials

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, 6-week trial of a formulation of AMZ001 once daily versus placeb...

Begins enrollment this month
Osteoarthritis of Knee
Osteoarthritis, Knee
Drug: Placebo gel
Drug: AMZ001 Diclofenac gel

The purpose of this study is to measure the efficacy and safety of baxdrostat in participants with uHTN or rHTN. The main objective is to compare the...

Enrolling
Resistant Hypertension
Uncontrolled Hypertension
Drug: Placebo
Drug: Baxdrostat

This is an exploratory study with the aim to gain insight and potentially generate hypotheses on health benefits of feeding with study product. This...

Enrolling
Healthy Subjects
Other: Control Formula
Other: Test Formula

This is a phase 2, randomized, double-blind, placebo-controlled trial of multiple doses and multiple administrations of LEVI-04 for the treatment of...

Active, not recruiting
Joint Diseases
Arthritis
Drug: LEVI-04
Other: Placebo:

Trial sponsors

Amgen logo
A
AstraZeneca logo
B
Danone logo
L

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems